25 May 2013
Keywords: Functional Technologies, Malaria treatment, Yeast-based approach
Article | 06 September 2010
In a second announcement last week of developments in the fight against malaria, Canadian firm Functional Technologies (TSX-V: FEB), in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 September 2010
7 September 2010
24 May 2013
© 2013 thepharmaletter.com